| Literature DB >> 30100739 |
Qing-Wei Zhang1, Jia-Yu Song2, Jiang-Hua Yu1, Ming-Zhen Sun2, Si-Yuan Tang1, Shao-Zhe Yang1, Lei-Jia Cao1, Hui-Fen Wang1, Li-Na Cui1, Xiu-Hong Fu1.
Abstract
PURPOSE: In this paper, the association between polymorphisms of IFN-γ +874T/A (rs2430561), IFN-γR1 -56 T/C (rs2234711), IFN-γR1 +95 C/T (rs7749390), and IFN-γR1 -611A/G (rs 1327474) and human papillomavirus (HPV) susceptibility was investigated in rural women from Luohe, Henan, China. PATIENTS AND METHODS: A total of 520 rural women were enrolled from Luohe, including 260 with HPV infection and mild dysplasia or less and 260 without HPV infection. Single-nucleotide polymorphisms (SNPs) of IFN-γ +874T/A, IFN-γR1 -56 T/C, IFN-γR1 +95 C/T and IFN-γR1 -611A/G were genotyped using TaqMan Pre-Designed SNP Genotyping Assays. Serum IFN-γ levels were measured using Human IFN-γ Quantikine ELISA Kit. Multivariate logistic regression analysis was performed to identify the SNPs associated with HPV susceptibility. Serum IFN-γ levels were compared between different genotypes.Entities:
Keywords: IFN-γ; IFN-γR1; human papillomavirus; single-nucleotide polymorphisms; susceptibility
Year: 2018 PMID: 30100739 PMCID: PMC6065563 DOI: 10.2147/OTT.S161544
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
General data of the case group and the control group
| Variables | Case group (n=260) | Control group (n=260) | ||
|---|---|---|---|---|
| Race | ||||
| Han | 251 (96.54%) | 250 (96.15%) | 0.055 | >0.05 |
| Hui/Mongol/Manchu | 9 (3.46%) | 10 (3.85%) | ||
| Educational level | ||||
| Primary school and below | 79 (30.38%) | 56 (21.54%) | 28.626 | <0.001 |
| Junior high school | 144 (55.38%) | 115 (44.23%) | ||
| Senior high school and above | 37 (14.24%) | 89 (34.23%) | ||
| Occupation | ||||
| Farmer | 218 (83.85%) | 177 (68.08%) | 18.001 | <0.001 |
| Worker | 29 (11.15%) | 53 (20.38%) | ||
| Civil servant/teacher/doctor | 13 (5.00%) | 30 (11.54%) | ||
| Annual family income (RMB) | ||||
| <10,000 | 199 (76.54%) | 148 (56.92%) | 26.01 | <0.001 |
| 10,000–20,000 | 42 (16.15%) | 60 (23.08%) | ||
| >20,000 | 19 (7.31%) | 52 (20.00%) | ||
| Marital status | ||||
| Married | 245 (94.23%) | 249 (95.77%) | 0.648 | >0.05 |
| Unmarried/divorced | 15 (5.77%) | 11 (4.23%) | ||
| Drinking status | ||||
| Yes | 234 (90.00%) | 239 (91.92%) | 0.585 | >0.05 |
| No | 26 (10.00%) | 21 (8.08%) | ||
| Smoking status | ||||
| Yes | 228 (87.69%) | 238 (91.54%) | 2.066 | >0.05 |
| No | 32 (12.31%) | 22 (8.46%) |
Note: Case group, women with HPV infection and mild dysplasia or less; control group, women without HPV infection.
Abbreviations: HPV, human papillomavirus; RMB, Renminbi.
Allele and genotype frequencies of the case group and the control group
| Single-nucleotide polymorphisms | Allele frequency | Genotype frequency | HWE | |||
|---|---|---|---|---|---|---|
| IFN-γ +874T/A | T | A | TT | AT | AA | |
| Case group | 224 | 296 | 72 | 80 | 108 | >0.05 |
| Control group | 302 | 218 | 119 | 79 | 62 | >0.05 |
| IFN-γR1 −56 T/C | T | C | TT | CT | CC | |
| Case group | 251 | 269 | 64 | 123 | 73 | >0.05 |
| Control group | 225 | 295 | 41 | 143 | 76 | >0.05 |
| IFN-γR1 +95 C/T | C | T | CC | CT | TT | |
| Case group | 252 | 268 | 67 | 118 | 75 | >0.05 |
| Control group | 249 | 271 | 62 | 125 | 73 | >0.05 |
| IFN-γR1 −611A/G | A | G | AA | AG | GG | |
| Case group | 467 | 53 | 218 | 31 | 11 | >0.05 |
| Control group | 458 | 62 | 213 | 32 | 15 | >0.05 |
Notes:
P<0.05, vs genotype frequency of the control group.
Abbreviations: HWE, Hardy–Weinberg equilibrium; IFN, interferon.
Association between polymorphism of IFN-γ +874T/A, IFN-γR1 −56 T/C, IFN-γR1 +95 C/T, IFN-γR1 −611A/G and HPV susceptibility
| Genotypes | Regression coefficient | Standard error | Wald | OR | 95% CI | |
|---|---|---|---|---|---|---|
| IFN-γ +874 | 10.668 | 0.003 | ||||
| TT | – | – | Ref=1 | |||
| AT | 0.316 | 0.167 | 8.639 | 1.672 | 1.0912–2.563 | 0.014 |
| AA | 0.425 | 0.226 | 12.639 | 2.874 | 1.872–4.414 | <0.001 |
| IFN-γR1 −56 | 1.217 | 0.203 | ||||
| TT | – | – | Ref=1 | |||
| CT | 0.249 | 0.136 | 1.329 | 0.551 | 0.232–1.157 | 0.187 |
| CC | 0.273 | 0.148 | 1.208 | 0.615 | 0.396–1.398 | 0.209 |
| IFN-γR1 +95 | 1.054 | 0.264 | ||||
| CC | – | – | Ref=1 | |||
| CT | 0.357 | 0.192 | 1.145 | 0.874 | 0.491–1.586 | 0.241 |
| TT | 0.282 | 0.159 | 0.967 | 0.951 | 0.619–1.835 | 0.318 |
| IFN-γR1 −611 | 0.987 | 0.296 | ||||
| AA | – | – | Ref=1 | |||
| AG | 0.174 | 0.126 | 0.871 | 0.946 | 0.608–1.826 | 0.349 |
| GG | 0.225 | 0.137 | 1.238 | 0.717 | 0.401–1.479 | 0.195 |
Abbreviations: HPV, human papillomavirus; IFN, interferon; OR, odds ratio; Ref, reference.
Figure 1Association between IFN-γ +874T/A polymorphism and human papilloma-virus susceptibility.
Note: IFN-γ +874 TT was used as Ref.
Abbreviations: IFN, interferon; OR, odds ratio; Ref, reference.
Serum IFN-γ levels in different genotypes of IFN-γ +874T/A
| Genotypes | Different genotypes (n) | Serum IFN-γ levels (pg/mL) |
|---|---|---|
| IFN-γ +874 TT | 72 | 2.86±1.14 |
| IFN-γ +874 AT | 80 | 1.57±0.79 |
| IFN-γ +874 AA | 108 | 0.41±0.22 |
| 8.947 | ||
| <0.001 |
Notes:
P<0.05, vs IFN-γ +874 TT.
P<0.05, vs IFN-γ +874 AT.
Abbreviation: IFN, interferon.